Bedaquiline resistance in drug-resistant tuberculosis HIV co-infected patients
Camus NimmoAfrica Health Research Institute, Durban, South AfricaJames MillardAfrica Health Research Institute, Durban, South AfricaKayleen BrienAfrica Health Research Institute, Durban, South AfricaSashen MoodleyAfrica Health Research Institute, Durban, South AfricaLucy van DorpUCL Genetics Institute, University College London, London, UKKeeren LutchminarainNational Health Laboratory Service, Durban, South AfricaAllison WolfDept of Medicine, Columbia University Medical Center, New York, NY, USAAlison D. GrantAfrica Health Research Institute, Durban, South AfricaFrançois BallouxUCL Genetics Institute, University College London, London, UKAlexander S. PymAfrica Health Research Institute, Durban, South AfricaNesri PadayatchiCAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South AfricaMax R. O’DonnellCAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa [email protected]
2020en
ABI
Annotatsiya
<b>Genetic mutations linked to bedaquiline resistance were found before starting treatment and acquired during treatment in patients with drug-resistant TB and HIV in KwaZulu-Natal, South Africa. Routine bedaquiline resistance testing needs to be accelerated.</b>http://bit.ly/2vnL4VY
Hali tarjima qilinmagan
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba